StrokeNCT07921108
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
A study testing App-based combined action observation and mirror therapy and App-based action observation therapy in people with Stroke and Upper Extremity Paresis, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
Trial summary
Background \& Objectives Upper extremity paresis represents one of the most prevalent and debilitating neurological sequelae following stroke, severely compromising survivors' independence in activities of daily living (ADLs). Read more about this study
- Who is it for?
- Ages 20 to 80 years
- Conditions the study is for
- Stroke, Upper Extremity Paresis
- What is being tested?
- App-based combined action observation and mirror therapy and App-based action observation therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTaiwan
- Study dates
- 30 Jun 2026to Jul 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Aged between 20 and 80 years.
- First-ever unilateral hemispheric or brainstem stroke confirmed by neuroimaging (brain CT or MRI).
- Subacute stroke stage, defined as stroke onset between 1 and 6 months prior to study enrollment.
- Baseline Fugl-Meyer Assessment for Upper Extremity (FMA-UE) score between 20 and 60, indicating moderate to mild-moderate upper limb motor impairment.
- Preserved cognitive function sufficient to understand and follow verbal instructions, with the ability to operate a smartphone or touch-screen mobile device.
Who cannot join
- Diagnosis of global aphasia or severe receptive aphasia that precludes basic verbal communication or comprehension of study tasks.
- Presence of severe hemispatial neglect.
- Coexisting significant medical conditions or musculoskeletal disorders that substantially restrict the passive range of motion or active movement of the paretic upper limb.
- Inability or refusal to use mobile touch-screen devices.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Chia-Ying Chung, M.D. contact
Taiwan1 site, 1 recruiting
- Recruiting
Chang Gung Memorial Hospital
Taoyuan
Chih-Chi Chen, M.D., 001-886-3-3281200 ext. 3846, claudia5477@gmail.com
Chia-Ying Chung, M.D., 001-886-3-3281200 ext. 3846
About this study
Official title: Effects of Mobile Device Delivered Action Observation Therapy and Mirror-based Action Observation Therapy for Post- Stroke Telerehabilitation: A Randomized Control Trial
Background \& Objectives
Upper extremity paresis represents one of the most prevalent and debilitating neurological sequelae following stroke, severely compromising survivors' independence in activities of daily living (ADLs). Among evidence-based interventions, action observation therapy (AOT) and mirror therapy (MT) have demonstrated clinical efficacy in augmenting upper limb functional recovery. Concurrently, telerehabilitation has emerged as a promising modality due to its clinical efficacy, accessibility, and cost-effectiveness. However, no prior investigation has directly compared telerehabilitation-delivered AOT alone versus combined AOT with mirror therapy (AOT-MT) in subacute stroke. This study aims to evaluate and compare the therapeutic effects of these two digital intervention paradigms on upper limb motor recovery and functional outcomes.
Read more
Methods \& Technical Development
A proprietary cross-platform mobile web application ("Neuro-Mirror Pro") was developed and clinically deployed. The platform incorporates standardized 12-movement upper extremity training modules, client-side WebRTC and CSS image rendering ensuring strict privacy compliance without cloud video storage, and adherence-optimizing features including breakpoint-resume tracking logic.
Clinically, this study is a prospective, assessor-blinded, randomized controlled trial. Subacute stroke survivors with unilateral hemiparesis are recruited from an inpatient stroke rehabilitation ward. Eligible participants are stratified by baseline motor impairment severity (FMA-UE score) and the affected side (left vs. right hemiparesis), and subsequently randomized (1:1) to receive either app-based AOT alone or app-based combined AOT-MT. Both arms undergo a 4-week telerehabilitation intervention (36 minutes daily) in conjunction with conventional occupational therapy (1 hour daily on weekdays).
Outcome Measures
The primary outcome is upper extremity motor function assessed by the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). Secondary outcomes include the modified Rankin Scale (mRS), Box and Block Test (BBT), ABILHAND questionnaire, short-form Quality of Movement Inventory (QMI), and app adherence/feasibility metrics. All outcomes are evaluated at baseline, 4 weeks (post-intervention), and 12 weeks (follow-up).
Read the detailed description
This study is a prospective, assessor-blinded, randomized controlled trial designed to evaluate and compare the therapeutic effects of a proprietary mobile web-based telerehabilitation platform delivering action observation therapy alone (AOT) versus combined action observation therapy with mirror therapy (AOT-MT) for upper extremity motor recovery in subacute stroke survivors.
Upper extremity hemiparesis is a prevalent and disabling complication following stroke, significantly limiting functional independence and participation in daily living. While conventional in-person rehabilitation yields positive outcomes, post-discharge adherence is often constrained by mobility limitations, geographic barriers, and clinical resource burdens. Telerehabilitation through mobile health (mHealth) applications offers a scalable and accessible alternative. However, clinical evidence directly comparing telerehabilitation-delivered AOT versus combined AOT-MT remains limited.
To address this gap, this trial utilizes "Neuro-Mirror Pro," a cross-platform mobile web telerehabilitation application. The software incorporates standardized 12-movement upper extremity rehabilitation modules, client-side WebRTC and CSS image transformation to achieve real-time mirror illusions without transferring raw patient video to cloud servers (ensuring data privacy), and breakpoint-resume tracking to optimize patient adherence.
Participants with subacute stroke (onset > 1 month) presenting with unilateral hemiparesis are recruited from an inpatient rehabilitation unit. Following baseline evaluation, participants are stratified by motor impairment severity (Fugl-Meyer Assessment for Upper Extremity, FMA-UE) and the side of hemiparesis (left vs. right), and then randomized (1:1) into either the AOT group or the combined AOT-MT group.
Both groups receive a 4-week telerehabilitation regimen consisting of 36 minutes of daily digital training, administered alongside conventional occupational therapy (1 hour daily on weekdays). Comprehensive outcome assessments are performed at baseline (pre-intervention), at 4 weeks (immediately post-intervention), and at 12 weeks post-baseline to assess retention and long-term functional recovery.
- Conditions
- Stroke, Upper Extremity Paresis
- Being tested
- App-based combined action observation and mirror therapy, App-based action observation therapy
- Keywords
- Stroke, Upper extremity rehabilitation, Telerehabilitation, Action observation therapy (AOT), Mirror therapy (MT)
- Medical subject headings
- Stroke, Paresis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
App-based combined action observation and mirror therapyBehavioural
Participants receive a 4-week telerehabilitation regimen delivered via the "Neuro-Mirror Pro" mobile web application, consisting of 36 minutes per daily session, 5 days per week, in addition to regular conventional occupational therapy (1 hour daily on weekdays). The intervention integrates action observation therapy with client-side mirrored visual feedback. Participants observe standardized video demonstrations of 12 upper extremity functional movements while actively performing the movements. Real-time visual feedback is rendered locally using client-side WebRTC and CSS horizontal inversion, creating the visual illusion that the paretic arm is moving smoothly, thereby stimulating motor cortex reorganization without transmitting raw video data to external servers.
App-based action observation therapyBehavioural
Participants receive a 4-week telerehabilitation regimen delivered via the "Neuro-Mirror Pro" mobile web application, consisting of 36 minutes per daily session, 5 days per week, in addition to regular conventional occupational therapy (1 hour daily on weekdays). The intervention consists of action observation therapy alone. Participants observe standardized video demonstrations of 12 upper extremity functional movements and actively perform the observed actions without mirrored visual feedback. Training adherence and completion are recorded client-side to ensure compliance and privacy without cloud video storage.
| Study group | Role | What they receive |
|---|---|---|
| AOT-MT Group | Experimental | Participants receive a 4-week telerehabilitation intervention (36 minutes/day, 5 days/week) combining action observation therapy with client-side mirrored visual feedback via the "Neuro-Mirror Pro" mobile web platform, alongside conventional occupational therapy (1 hour/day on weekdays). Receives: Behavioral: App-based combined action observation and mirror therapy |
| AOT Group | Active comparator | Participants receive a 4-week telerehabilitation intervention (36 minutes/day, 5 days/week) consisting of action observation therapy alone without mirror visual feedback via the "Neuro-Mirror Pro" mobile web platform, alongside conventional occupational therapy (1 hour/day on weekdays). Receives: Behavioral: App-based action observation therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline in Fugl-Meyer Assessment for Upper Extremity (FMA-UE) Score
The Fugl-Meyer Assessment for Upper Extremity (FMA-UE) is a widely recognized, stroke-specific performance-based impairment index designed to assess upper extremity motor recovery. It evaluates voluntary movement, reflex activity, grasping, and wrist/hand coordination across 33 items. Each item is scored on a 3-point ordinal scale (0 = cannot perform, 1 = performs partially, 2 = performs fully), yielding a total score ranging from 0 to 66, with higher scores indicating better upper limb motor function.
Measured: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Secondary outcomes (5)
Change from Baseline in modified Rankin Scale (mRS) Score
The modified Rankin Scale (mRS) is a clinician-reported single-item measure of global disability and functional dependence following stroke. The scale ranges from 0 (no symptoms at all) to 6 (dead), with 0-2 indicating functional independence, 3 indicating moderate disability (requiring some help but able to walk without assistance), and 4-5 indicating severe disability and dependence. Lower scores reflect superior global functional independence.
Measured: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Change from Baseline in Box and Block Test (BBT) Score
The Box and Block Test (BBT) evaluates gross manual dexterity by measuring the number of wooden blocks transferred one by one from one compartment of a divided box to the other within 60 seconds using the affected upper extremity. Higher scores indicate superior manual dexterity.
Measured: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Change from Baseline in ABILHAND Questionnaire Score
The ABILHAND questionnaire is a patient-reported measure of manual ability during daily bimanual activities. Patients rate their perceived difficulty on 23 representative daily manual tasks as impossible (0), difficult (1), or easy (2). Ordinal scores are converted via Rasch analysis into a linear logit measure, where higher logit scores indicate greater ease and manual capability.
Measured: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Change from Baseline in Short-form Quality of Movement Inventory (QMI) Score
The short-form Quality of Movement Inventory (QMI) assesses the qualitative performance and movement smoothness of the paretic upper limb during specific motor tasks. Higher scores denote improved quality of movement and less compensatory strategies.
Measured: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Telerehabilitation System Feasibility, Usability, and Training Adherence
Feasibility, usability, and adherence are evaluated using a multi-metric approach: (1) training adherence rate, measured as the percentage of completed digital sessions relative to the prescribed 20 sessions (36 minutes daily, 5 days per week over 4 weeks) monitored via client-side breakpoint-resume tracking within the Neuro-Mirror Pro application; (2) dropout/retention rate; (3) platform usability assessed via the System Usability Scale (SUS, scored 0-100, where higher scores indicate superior usability); (4) user acceptance, perceived ease of use, and satisfaction assessed using the Technology Acceptance Model-2 (TAM-2, rated on a 5-point Likert scale) and the USE (Usefulness, Satisfaction, and Ease of Use) questionnaire (rated on a 7-point Likert scale); and (5) intervention safety, evaluated by tracking any study-related adverse events during the 4-week period.
Measured: 4 weeks (immediately post-intervention)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Nov 2026
- Study start30 Jun 2026
- Primary completionJul 2028 (estimated)
- Study completionJul 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- More trials run by Chang Gung Memorial HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chang Gung Memorial Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Chih-Chi ,Chen, Chang Gung Memorial Hospital
- Investigators
- Chih Chi Chen, M.D., Principal investigator, Chang Gung Memorial Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07921108
- Sponsor's protocol ID
- 202302120B0C1002
- Other IDs
- NMRPG3Q6112
- Status last verified
- Nov 2026
- First submitted
- 2 Nov 2026
- Last updated
- 6 Nov 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be publicly shared to protect participant confidentiality and privacy in accordance with institutional review board and data governance regulations. Aggregated trial results and study outcomes will be fully published in peer-reviewed scientific journals.
Study at a glance
From the registry record, last updated by the sponsor on 6 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Mobile Device Delivered Action Observation Therapy and Mirror-based Action Observation Therapy for Post- Stroke Telerehabilitation: A Randomized Control Trial
- ClinicalTrials.gov ID
- NCT07921108
- Acronym / sponsor ID
- 202302120B0C1002
- Conditions
- Stroke, Upper Extremity Paresis
- Keywords
- Stroke, Upper extremity rehabilitation, Telerehabilitation, Action observation therapy (AOT), Mirror therapy (MT)
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Chang Gung Memorial HospitalUniversity, hospital or other
- Study start
- 30 Jun 2026 (actual)
- Primary completion
- Jul 2028 (estimated)
- Study completion
- Jul 2028 (estimated)
- First posted
- 6 Nov 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background \& Objectives
Upper extremity paresis represents one of the most prevalent and debilitating neurological sequelae following stroke, severely compromising survivors' independence in activities of daily living (ADLs). Among evidence-based interventions, action observation therapy (AOT) and mirror therapy (MT) have demonstrated clinical efficacy in augmenting upper limb functional recovery. Concurrently, telerehabilitation has emerged as a promising modality due to its clinical efficacy, accessibility, and cost-effectiveness. However, no prior investigation has directly compared telerehabilitation-delivered AOT alone versus combined AOT with mirror therapy (AOT-MT) in subacute stroke. This study aims to evaluate and compare the therapeutic effects of these two digital intervention paradigms on upper limb motor recovery and functional outcomes.
Methods \& Technical Development
A proprietary cross-platform mobile web application ("Neuro-Mirror Pro") was developed and clinically deployed. The platform incorporates standardized 12-movement upper extremity training modules, client-side WebRTC and CSS image rendering ensuring strict privacy compliance without cloud video storage, and adherence-optimizing features including breakpoint-resume tracking logic.
Clinically, this study is a prospective, assessor-blinded, randomized controlled trial. Subacute stroke survivors with unilateral hemiparesis are recruited from an inpatient stroke rehabilitation ward. Eligible participants are stratified by baseline motor impairment severity (FMA-UE score) and the affected side (left vs. right hemiparesis), and subsequently randomized (1:1) to receive either app-based AOT alone or app-based combined AOT-MT. Both arms undergo a 4-week telerehabilitation intervention (36 minutes daily) in conjunction with conventional occupational therapy (1 hour daily on weekdays).
Outcome Measures
The primary outcome is upper extremity motor function assessed by the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). Secondary outcomes include the modified Rankin Scale (mRS), Box and Block Test (BBT), ABILHAND questionnaire, short-form Quality of Movement Inventory (QMI), and app adherence/feasibility metrics. All outcomes are evaluated at baseline, 4 weeks (post-intervention), and 12 weeks (follow-up).
Detailed description
This study is a prospective, assessor-blinded, randomized controlled trial designed to evaluate and compare the therapeutic effects of a proprietary mobile web-based telerehabilitation platform delivering action observation therapy alone (AOT) versus combined action observation therapy with mirror therapy (AOT-MT) for upper extremity motor recovery in subacute stroke survivors.
Upper extremity hemiparesis is a prevalent and disabling complication following stroke, significantly limiting functional independence and participation in daily living. While conventional in-person rehabilitation yields positive outcomes, post-discharge adherence is often constrained by mobility limitations, geographic barriers, and clinical resource burdens. Telerehabilitation through mobile health (mHealth) applications offers a scalable and accessible alternative. However, clinical evidence directly comparing telerehabilitation-delivered AOT versus combined AOT-MT remains limited.
To address this gap, this trial utilizes "Neuro-Mirror Pro," a cross-platform mobile web telerehabilitation application. The software incorporates standardized 12-movement upper extremity rehabilitation modules, client-side WebRTC and CSS image transformation to achieve real-time mirror illusions without transferring raw patient video to cloud servers (ensuring data privacy), and breakpoint-resume tracking to optimize patient adherence.
Participants with subacute stroke (onset > 1 month) presenting with unilateral hemiparesis are recruited from an inpatient rehabilitation unit. Following baseline evaluation, participants are stratified by motor impairment severity (Fugl-Meyer Assessment for Upper Extremity, FMA-UE) and the side of hemiparesis (left vs. right), and then randomized (1:1) into either the AOT group or the combined AOT-MT group.
Both groups receive a 4-week telerehabilitation regimen consisting of 36 minutes of daily digital training, administered alongside conventional occupational therapy (1 hour daily on weekdays). Comprehensive outcome assessments are performed at baseline (pre-intervention), at 4 weeks (immediately post-intervention), and at 12 weeks post-baseline to assess retention and long-term functional recovery.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| AOT-MT Group | Experimental | Behavioral: App-based combined action observation and mirror therapyParticipants receive a 4-week telerehabilitation intervention (36 minutes/day, 5 days/week) combining action observation therapy with client-side mirrored visual feedback via the "Neuro-Mirror Pro" mobile web platform, alongside conventional occupational therapy (1 hour/day on weekdays). |
| AOT Group | Active comparator | Behavioral: App-based action observation therapyParticipants receive a 4-week telerehabilitation intervention (36 minutes/day, 5 days/week) consisting of action observation therapy alone without mirror visual feedback via the "Neuro-Mirror Pro" mobile web platform, alongside conventional occupational therapy (1 hour/day on weekdays). |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Aged between 20 and 80 years.
- First-ever unilateral hemispheric or brainstem stroke confirmed by neuroimaging (brain CT or MRI).
- Subacute stroke stage, defined as stroke onset between 1 and 6 months prior to study enrollment.
- Baseline Fugl-Meyer Assessment for Upper Extremity (FMA-UE) score between 20 and 60, indicating moderate to mild-moderate upper limb motor impairment.
- Preserved cognitive function sufficient to understand and follow verbal instructions, with the ability to operate a smartphone or touch-screen mobile device.
Key exclusion criteria (4 listed)
- Diagnosis of global aphasia or severe receptive aphasia that precludes basic verbal communication or comprehension of study tasks.
- Presence of severe hemispatial neglect.
- Coexisting significant medical conditions or musculoskeletal disorders that substantially restrict the passive range of motion or active movement of the paretic upper limb.
- Inability or refusal to use mobile touch-screen devices.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| App-based combined action observation and mirror therapyParticipants receive a 4-week telerehabilitation regimen delivered via the "Neuro-Mirror Pro" mobile web application, consisting of 36 minutes per daily session, 5 days per week, in addition to regular conventional occupational therapy (1 hour daily on weekdays). The intervention integrates action observation therapy with client-side mirrored visual feedback. Participants observe standardized video demonstrations of 12 upper extremity functional movements while actively performing the movements. Real-time visual feedback is rendered locally using client-side WebRTC and CSS horizontal inversion, creating the visual illusion that the paretic arm is moving smoothly, thereby stimulating motor cortex reorganization without transmitting raw video data to external servers. | Behavioural | AOT-MT Group |
| App-based action observation therapyParticipants receive a 4-week telerehabilitation regimen delivered via the "Neuro-Mirror Pro" mobile web application, consisting of 36 minutes per daily session, 5 days per week, in addition to regular conventional occupational therapy (1 hour daily on weekdays). The intervention consists of action observation therapy alone. Participants observe standardized video demonstrations of 12 upper extremity functional movements and actively perform the observed actions without mirrored visual feedback. Training adherence and completion are recorded client-side to ensure compliance and privacy without cloud video storage. | Behavioural | AOT Group |
Primary outcome
Change from Baseline in Fugl-Meyer Assessment for Upper Extremity (FMA-UE) Score
Time frame: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
The Fugl-Meyer Assessment for Upper Extremity (FMA-UE) is a widely recognized, stroke-specific performance-based impairment index designed to assess upper extremity motor recovery. It evaluates voluntary movement, reflex activity, grasping, and wrist/hand coordination across 33 items. Each item is scored on a 3-point ordinal scale (0 = cannot perform, 1 = performs partially, 2 = performs fully), yielding a total score ranging from 0 to 66, with higher scores indicating better upper limb motor function.
5 secondary outcomes
Change from Baseline in modified Rankin Scale (mRS) Score
Time frame: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Change from Baseline in Box and Block Test (BBT) Score
Time frame: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Change from Baseline in ABILHAND Questionnaire Score
Time frame: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Change from Baseline in Short-form Quality of Movement Inventory (QMI) Score
Time frame: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline
Telerehabilitation System Feasibility, Usability, and Training Adherence
Time frame: 4 weeks (immediately post-intervention)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Nov 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be publicly shared to protect participant confidentiality and privacy in accordance with institutional review board and data governance regulations. Aggregated trial results and study outcomes will be fully published in peer-reviewed scientific journals.
Related trials for Stroke
Active, not recruitingObservational study
Symptomatic Carotid Outcomes Registry
Carotid Stenosis, Ischemic Stroke
RecruitingPhase 3
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Atrial Fibrillation (AF)
Not yet recruiting
The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke
Stroke
Recruiting
A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With Acute Ischemic Stroke
Ischemic Stroke
RecruitingObservational study
Role of EEG in Differentiation Between Ischemic and Hemorrhagic Stroke
Acute Ischemic Stroke, Acute Haemorrhagic Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Chia-Ying Chung, M.D. contact
Chih Chi Chen, M.D. principal investigator
Chang Gung Memorial Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing App-based combined action observation and mirror therapy and App-based action observation therapy in people with Stroke and Upper Extremity Paresis, run by Chang Gung Memorial Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 6 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chih-Chi Chen, M.D. (001-886-3-3281200 ext. 3846, claudia5477@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline in Fugl-Meyer Assessment for Upper Extremity (FMA-UE) Score (time frame: Baseline, 4 weeks (immediately post-intervention), and 12 weeks post-baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2026.